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Toxicity on Growth and Mineral Metabolism of Young Rats. 
(1965)  Directed by:  Dr. Aden C. Magee. pp. 71. 
The effects of high levels of manganese on growth, 
hemoglobin levels, liver constituents, and bone mineraliza- 
tion of young male rats were investigated in this study. 
Results from this study indicate that high levels of 
dietary manganese are associated with marked decreases in 
growth which could be partially alleviated by the addition 
of 10% of distiller's dried solubles.  The data suggest 
that a high level of protein may accentuate, rather than 
reduce, the effects of manganese toxicity on growth in rats 
under certain conditions. 
Rats fed excessive dietary manganese showed marked 
decreases in liver deposition of iron. Since results 
indicate that this effect can be overcome by the addition 
of iron to the high manganese diet, the supplemental iron 
could be alleviating the effect of manganese by supplying 
the animal with an available form to replace that lost by 
the action of manganese. 
Excessive manganese in the diet resulted in sharp 
decreases in hemoglobin concentration which could be pre- 
vented by the addition of copper and iron to the high 
manganese diet. 
The manganese content of the bones and livers of the 
animals fed high levels of this mineral was significantly 
increased.  In this study, the addition of calcium and phos- 
phorus was the only supplement capable of preventing this 
marked increase in manganese deposition. 
Results from this study showed that feeding high 
levels of manganese had no adverse effect on bone minerali- 
zation with respect to calcium, phosphorus, and magnesium 
deposition. 
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CHAPTER I 
INTRODUCTION 
The essential trace minerals in animal nutrition have 
been so designated because they have been found to perform 
vital functions and/or to affect living processes.  One of 
these elements which has been studied is manganese and 
interest in this particular mineral was stimulated by the 
revelation that inadequate intakes caused perosis and nutri- 
tional chondrodystrophy in poultry.  Subsequent studies by 
various workers further established the necessity of 
manganese for growth, skeletal development, reproductive 
performance, and the functioning of the central nervous 
system. 
Although manganese is an essential dietary nutrient 
for animals, excessive intakes of this mineral have been 
shown to be antagonistic to other dietary components. 
Since forage crops and mineral supplements frequently con- 
tain high levels of manganese, complete information concern- 
ing the biological effects of excessive dietary intakes of 
this mineral on the animal body is of scientific importance. 
Investigators have observed that a number of biolog- 
ical changes occur in animals receiving high or excessive 
intakes of manganese.  Massive consumption of this element 
has been shown to interfere with the retention and utiliza- 
tion of phosphorus, calcium, copper, magnesium, and iron. 
In man, manganese toxicity has been characterized by 
extrapyramidal manifestations which are occasionally accom- 
panied by a type of pneumonitis.  This disease has been 
observed among miners following a chronic inhalation of 
manganese dusts.  The condition occurs even though the body 
appears to maintain the actual tissue concentration of 
manganese within normal limits.  The same process seems to 
be responsible for the rapid control of this element and for 
the degenerative disease; however, the mechanisms involved 
are not understood. 
Since the accumulation of evidence demonstrates that 
an excessive intake of manganese affects the physiological 
responses within the animal body, further study is necessary 
for the clarification of the biological activity of this 
mineral. 
CHAPTER II 
REVIEW OF LITERATURE 
Within recent years, nutritionists have become 
interested in nutrient imbalances and interrelationships. 
Of particular interest have been the imbalances and inter- 
relationships that exist between minerals.  Recent research 
findings indicate that high dietary levels of certain 
mineral nutrients have profound biological effects on 
various animal species.  Manganese is one of those minerals 
which has attracted the attention of some researchers. 
This element is omnipresent in all food stuffs, it is found 
in steady concentration in the tissues of mammals (1), and 
several research studies (2, 3) have established that 
physiological functions exist for this nutrient.  Manganese 
is widely used in mineral supplements and occasionally very 
high levels of this mineral occur in forages which are used 
for animal consumption. 
At present actual dietary requirements for manganese 
have not been determined, but in 1937 Heller and Penquite 
(4) reported that a dietary level of .48% of manganese was 
highly toxic to young chicks.  Gallup and Norris (5) found 
that the growth of hens was not affected by a level of 
0.1% of manganese in the diet while dietary levels of 
0.1% - 0.2% of manganese were not sufficient for the growth 
of rats (6).  Grummer e_t aj^. (7), however, reported that a 
level of 0.05% of dietary manganese retarded growth of 
young pigs. 
Fore and Morton (1) have shown that bone seems to be 
the site of highest manganese concentration with the liver 
as another possible site of storage.  Gallup et al. (8) 
demonstrated that the ingestion of large amounts of dietary 
manganese was followed by the development of elevated con- 
centrations of this mineral in the liver. 
Gubler et al. (9) reported that the addition of a 
high level of manganese to the diets of rats was associated 
with no change in the liver copper levels; however, these 
researchers postulated that manganese formed a complex with 
copper which resulted in the latter mineral being unavail- 
able for use by the animal body.  They also postulated that 
manganese blocked the action of certain copper-containing 
enzymes.  Simultaneous administration of large amounts of 
copper and manganese resulted in a marked increase in total 
body copper level even though a microcytic hypochromic 
anemia still existed. 
Saltman et al. (10) found that manganese completely 
inhibited the uptake and release of iron by liver slices. 
This investigation suggested the existence of a common 
pathway for both these minerals.  Further evidence of a 
manganese-iron antagonism has been shown in lambs (11), in 
rabbits, and in pigs (12). 
Diets containing supplements up to 5000 p.p.m. of 
manganese resulted in decreased concentrations of iron in 
the livers, spleens, and kidneys of lambs with normal hemo- 
globin levels.  Hemoglobin regeneration was severely retarded 
and serum iron levels were decreased, however, in anemic 
lambs which were fed diets containing 1000 or 2000 p.p.m. of 
manganese (11).  Depressed hemoglobin formation in rabbits 
and pigs receiving diets supplemented with 1250 and 2000 
p.p.m. of manganese was alleviated with supplements of 400 
p.p.m. of iron (12).  Matrone et al_. (12) have theorized 
that manganese interferes with iron absorption rather than 
with hematopoiesis.  The mechanism of this interference is 
unknown. 
In addition to copper and iron, several studies have 
indicated the possibility of interrelationships between 
manganese and other mineral nutrients.  Levels of manganese 
in excess of 2000 p.p.m. have been shown to interfere with 
phosphorus retention in rats (6).  Chornock et a_l. (13) 
reported that a level of 2000 p.p.m. of manganese consumed 
by rats resulted in marked increases in fecal calcium 
losses, severe rachetic conditions, and a negative phos- 
phorus balance.  Reid et al. (14) demonstrated that a 
manganese sulfate supplement interfered with calcium metab- 
olism in cattle.  The deleterious effects of high levels of 
magnesium on manganese metabolism in turkey poults could be 
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overcome by increasing the manganese level of the diet (15). 
Recently, Magee  obtained data which indicated a possible 
relationship between manganese and zinc. 
Although these studies indicate that manganese 
interferes, in some way, with the growth mechanism of animals 
and that the effects of excessive manganese in the diet are 
fairly extensive, the mechanisms involved have not been 
determined. 
A. C. Magee, 1964.  Unpublished data. 
CHAPTER III 
EXPERIMENTAL PROCEDURES 
The objectives of this study were to investigate the 
nature of the interference of high levels of manganese (a) 
on growth and hemoglobin levels of young rats, (b) on the 
metabolism of copper, iron, zinc, and manganese, and (c) on 
bone mineralization. 
Since this study consisted of three experiments, 
procedures pertaining to a particular experiment will be 
discussed separately.  Several procedures which are common 
to all of the experiments will be discussed in the following 
paragraphs. 
Young male rats1 of the Sprague-Dawley strain were 
used for all of the experiments in the study.  The rats 
were housed in individual wire-bottom cages and were given 
free access to food and water.  Each experiment lasted four 
weeks.  The animals in each experiment were randomized into 
replications according to initial body weights.  Test treat- 
ments utilized in a particular experiment were randomly 
assigned to individual cages within a replication. 
The composition of the basal or control diet used 
1Sprague-Dawley rats purchased from Holtzman Company, 
Madison, Wisconsin. 
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throughout the study is shown in Table 1.  Materials tested 
were added to the basal diet at the expense of starch. 
At the termination of each experiment, randomly 
selected rats from each test diet were sacrificed.  Livers 
and femurs from each animal were removed for subsequent 
mineral analyses. 
A small portion of each liver was weighed separately 
on an analytical balance and dried in an oven at 35° C. for 
dry weight data.  The remainder of each liver was prepared 
for mineral analyses by wet ashing with nitric and perchloric 
acids on a hot plate.  The ash of each liver sample was 
dissolved in 3 ml. of 0.6N HC1 and brought to a volume of 
100 ml. with redistilled water. 
Copper and iron determinations of the liver samples 
were made by the methods of Parks e_t al. (16) and Kitzes 
et al. (17), respectively, as modified by Matrone et al_. 
(18).  In general, manganese and zinc contents were deter- 
2 
mined by means of an atomic absorption spectrophotometer. 
The exception occurred in Experiment 1 in which zinc was 
determined by the method of McCall et_ al. (19) . 
After the femurs were removed, they were kept in a 
freezer until they were prepared for mineral analyses.  At 
the time of preparation, the flesh was removed from the bone, 
and the bones were dried in an oven at 35° C. and weighed 
2Perkin-Elmer Model 303 Atomic Absorption Spectro- 
photometer, The Perkin-Elmer Corporation, Norwalk, 
Connecticut. 
^» 
TABLE 1 
COMPOSITION OF THE BASAL DIET 
Constituents per cent 
Casein3          19 
Corn starch"-1     62 
Vegetable fatc  10 
Mineral mix      4 
Vitamin mixe     2 
Cellulosef       2 
Cod liver oil9  1 
aVitamin Test Casein, Nutritional Biochemicals Corpo- 
ration, Cleveland, Ohio. 
bGlobe Easy-flow Corn Starch 3367, Corn Products 
Sales Company, Greensboro, North Carolina. 
cCrisco, Procter and Gamble Company, Cincinnati, Ohio. 
dSalt Mixture W, Nutritional Biochemicals Corporation, 
Cleveland, Ohio.  The composition of this salt mixture is 
listed as:  (in per cent) CaC03, 21.00; CuS04'5H20, 0.039; 
FeP04-2H20, 1.470; MnS04, 0.020; MgS04, 9.000; KA1 (S04)2- 
12H20, 0.009; KC1, 12.000: KH2P04, 31.000; KI, 0.005; NaCl, 
10.500; NaF, 0.057; and Ca3(P04)2, 14,900. 
eEach 100 gm. of vitamin mix contained (in milligrams)i 
0.1% vitamin Bi2 (with mannitol), 0.1; biotin, 1; folic acid, 
5; thiamine-HCl, 25; pyridoxine-HCl, 25; 2 methyl-naphtho- 
quinone, 50; riboflavin, 50; nicotinic acid, 50; Ca pantothe- 
nate, 150; p-aminobenzoic acid, 500; (in grams) inositol 5; 
Choline chloride, 7.5; DL-methionine, 30; and corn starch, 
56.6.  All vitamins and methionine were purchased from 
Nutritional Biochemicals Corporation, Cleveland, Ohio. 
fAlphacel, Nutritional Biochemicals Corporation, 
Cleveland, Ohio. 
9Cod liver oil, E. R. Squibb and Sons, New York.  This 
cod liver oil is listed to contain 1700 U. S. P. units of 
vitamin A and 170 U. S. P. units of vitamin D per 1 gram. 
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on an analytical balance.  The bones were wet ashed by the 
method previously outlined.  The ash of each bone sample 
was dissolved in 3 ml. of 0.6N HC1 and brought to a volume 
of 25 ml. with redistilled water.  Manganese was determined 
on the original dilution.  A second dilution was made for 
the calcium, phosphorus, and magnesium determinations. 
Phosphorus was determined by the method of Simonsen et al. 
(20).  In Experiment 2, calcium and magnesium determina- 
tions were made by the methods of Weybrew e_t aj^. (21) and 
Simonsen et al. (22), respectively.  Calcium and magnesium 
determinations were made by means of an atomic absorption 
spectrophotometer in Experiment 3. 
A randomized block design was used for each experi- 
ment, and all data were subjected to an analysis of variance. 
Statements of significance are based on odds of at least 19 
to 1 (p^.0.05).  Least significant difference (L.S.D.) 
values were calculated for each experiment to give an indi- 
cation of the difference between two treatment means which 
was required to show significance in a particular experiment. 
Experiment 1 
The purpose of this experiment was to compare the 
effects of high levels of manganese from various sources on 
growth, hemoglobin levels, and liver copper, iron, zinc, 
and manganese deposition.  A level of 1.0% of manganese in 
the forms of carbonate, chloride, and sulfate was 
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incorporated into separate diets.  Only liver samples were 
taken from randomly selected animals at the end of the 
experiment. 
Experiment 2 
The purpose of this experiment was to compare the 
effects of various levels of manganese on the growth and on 
hemoglobin levels, the deposition of copper, iron, man- 
ganese, and zinc in the liver, and the levels of calcium, 
phosphorus, magnesium, and manganese in the bones.  The 
levels of dietary manganese supplements, in the sulfate 
form, utilized in this experiment were 0.2 5%, 0.5%, and 
1.0%. 
At the end of the experimental period, liver and 
bone samples were removed from randomly selected animals on 
each experimental diet for subsequent mineral analyses. 
Experiment 3 
One of the techniques commonly used to study the 
nature of the effect of a mineral toxicity on the animal 
body has been to attempt to alleviate the adverse condi- 
tions caused by the mineral excess by adding various supple- 
ments to the diet.  There is the possibility that some of 
the types of supplements used to alleviate the effects of a 
mineral toxicity, such as zinc, could also alleviate the 
adverse effects of manganese toxicity.  The purpose of this 
experiment was to study the responses of manganese-fed rats 
12 
to 10% supplemental levels of distiller's dried solubles,3 
casein, soybean meal, blood albumin, alpha protein,4 and 
lactalbumin, a supplement of 0.8% calcium + 0.8% phos- 
phorus, and a supplement of 0.02% copper + 0.04% iron. 
After the four week experimental period, the livers 
and femurs of randomly selected animals on each diet were 
removed and prepared for mineral analyses. 
3Furnished by the Distillers Feed Research Council 
and the John F. Young Company, Cincinnati, Ohio. 
4Nutritional Biochemicals Corporation, Cleveland, 
Ohio. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Detailed data gathered from this investigation are 
presented in Appendix A, Tables 1-26. 
Experiment 1 
The addition of 1.0% of manganese to diets of young 
rats resulted in highly significant decreases (p^O.Ol) in 
weight gains, hemoglobin levels, and liver iron levels, and 
in increases in liver manganese levels which were signifi- 
cant at the 1% level of probability (Table 2).  In general, 
the presence of extra manganese in the diet was associated 
with increases in liver copper and zinc deposition.  These 
increases in copper and zinc concentrations in the man- 
ganese-fed rats, however, were not statistically different 
from those levels observed in the control animals.  Although 
there were some variations in the responses of the animals 
to the three manganese compounds, the effects of these three 
sources of manganese were similar. 
Experiment 2 
As the level of added manganese increased, there 
were progressive decreases in weight gains, hemoglobin con- 
centrations, liver iron levels, and liver zinc levels 
TABLE 2 
RESPONSE OF RATS TO A HIGH LEVEL OF DIETARY MANGANESE 
FROM THREE SOURCES (EXPERIMENT 1) 
Source 
of 
Level of 
Added 
Manganese 
Weight 
Gain at 
4 Weeksa 
Hemoglobin 
Level3 
Liver Constituents^3 
Manganese Cu Fe Mn Zn 
% gm. gm ./100 ml. 
blood 
mcg./gm. dry weight 
None — 176 12.07 21.80 357.28 6.16 45.52 
MnS04-H20 1.0 89 8.06 31.56 182.63 74.21 82.26 
MnCl2-4H20 1.0 94 6.44 18.00 120.52 38.01 55.88 
MnC03 1.0 28 6.59 31.48 119.99 29.31 57.92 
L.S.D. '0.05c 28 1.23 15.47 67.02 
23.03 46.26 
L.S.D, •0.01 38 1.68 22.23 
96.30 33.08 66.46 
aEach figure represents the mean of eight animals. 
bEach figure represents the mean of four animals. 
cLeast significant difference at specified probability levels, 
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(Table 3).  Increasing levels of manganese in the diet were 
also associated with marked increases in liver manganese 
levels.  In this experiment the addition of extra manganese 
to the diets of young rats had no apparent effect on copper 
concentrations in the livers. 
A level of 1.0% of extra manganese was associated 
with a highly significant increase (p^O.Ol) in bone cal- 
cium deposition (Table 4).  Increasing levels of added 
manganese were also associated with progressive decreases 
in bone magnesium deposition and marked increases in bone 
manganese and phosphorus levels. 
Experiment 3 
Mean growth and hemoglobin levels are shown in Table 5 
Liver data appear in Table 6 and bone data, in Table 7.  The 
effect of 1.0% of manganese on weight gains, hemoglobin con- 
centrations, liver iron and manganese levels, and bone 
manganese levels was similar to the results obtained in 
Experiments 1 and 2.  The addition of 1.0% of manganese had 
no significant effect on liver copper and zinc levels or 
on bone calcium, phosphorus, and magnesium levels in this 
experiment. 
The addition of 10% of distiller's dried solubles 
to the high manganese diet partially alleviated the adverse 
effect of manganese on weight gain.  The addition of all 
other supplements, with the exception of soybean meal, 
appeared to accentuate the severity of the effect of 
-*—I 
TABLE 3 
WEIGHT GAINS, HEMOGLOBIN LEVELS, AND LIVER MINERAL LEVELS OF RATS 
CONSUMING DIETS CONTAINING VARIOUS LEVELS OF MANGANESE 
(EXPERIMENT 2) 
Level of 
Added 
Weight 
Gain at 
4 Weeks3 
Hemoglobin 
Level9 
Liver Constituents 
Manganese Cu Fe Mn Zn 
% gm. gm./lOO ml. 
blood 
meg./gm. dry weight 
0.00 204 12.98 9.50 222.75 3.82 67.07 
0.25 190 11.94 9.23 129.75 7.68 63.38 
0.50 191 10.07 7.74 88.13 11.47 56.05 
1.00 95 7.60 9.27 57.63 21.84 47.97 
L0S D 
"0 05C 
15 .60 1.93 30.15 7.92 13.75 
L„S ,D '0 01 
20 .81 2.63 41.04 10.79 18.71 
Each Figure represents the mean of eight animals. 
■'Each figure represents the mean of four animals. 
:Least significant differences at specified probability levels. 
Oi 
_. 
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TABLE 4 
EFFECTS OF INCREASING LEVELS OF DIETARY MANGANESE 
ON MINERAL DEPOSITION IN THE BONES OF YOUNG RATSa 
(EXPERIMENT 2) 
Level of 
Manganese 
Bone Constituents 
% 
0.00 
0.25 
0.50 
1.00 
Ca Mg Mn 
mg./gm. dry weight 
1046.82    3.51    0.012 88.27 
728.04    3.32    0.013 72.94 
953.54    3.20    0.014 91.28 
2542.70    1.92    0.028 155.45 
L„SeD„    b  851.84    0.60    0.001     27.96 
L.S„D„       1159.41    0.81    0.002 38.05 
aEach figure represents the mean of eight 
animals. 
bLeast significant difference at specified 
probability levels. 
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TABLE 5 
EFFECTS OF VARIOUS SUPPLEMENTS ON WEIGHT GAINS 
AND HEMOGLOBIN LEVELS OF RATS FED HIGH LEVELS 
OF DIETARY MANGANESE3 (EXPERIMENT 3) 
Diet 
Weight Gain 
at 4 Weeks 
Hemoglobin 
Level 
Basal 
1.0% Mn 
1.0% Mn + 
dried 
1.0% Mn + 
1.0% Mn + 
1.0% Mn + 
1.0% Mn + 
1.0% Mn + 
1.0% Mn + 
1.0% Mn + 
Distiller's 
solubles 
0.8% Ca + 0.8% P 
10% Soybean meal 
10% Extra casein 
10% Alpha protein 
10% Lactalbumin 
10% Blood albumin 
0.02% Cu + 0.04% Fe 
L„S.D.005b 
L's-D-o.oi 
gm. gm./lOO ml. 
blood 
181 12.50 
128 8.75 
153 8.66 
110 8.73 
136 7.74 
92 8.14 
47 8.88 
61 8.43 
84 8.77 
39 12.85 
34 1.29 
45 1.73 
aEach figure represents the mean of six animals. 
bLeast significant difference at specified proba- 
bility levels. 
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TABLE 6 
EFFECTS OF VARIOUS SUPPLEMENTS ON LIVER MINERAL DEPOSITION 
OF RATS FED HIGH LEVELS OF DIETARY MANGANESE 
(EXPERIMENT 3) 
Die t 
Liver Constituents 
Cu Fe Mn Zn 
mcg./gm. dry weight 
Basal 17.49 301.21 4.69 73.51 
1.0% Mn 19.41 96.80 29.71 81.87 
1.0% Mn + 10% Distiller's 
dried solubles 20.73 84.53 18.29 71.56 
1.0% Mn + 0.8% Ca + 0 8% P 16.79 87.78 9.68 82.57 
1.0% Mn + 10% Soybean meal 13.48 85.91 21.57 79.60 
1.0% Mn + 10% Extra casein 20.55 92.20 19.33 103.19 
1.0% Mn + 10% Alpha pi otein 37.87 99.86 41.42 148.60 
1.0% Mn + 10% Lactalbumin 27.77 108.86 31.28 88.68 
1.0% Mn + 10% 
albumin 
Blood 
18.37 96.57 35.98 135.08 
1.0% Mn + 0.02% Cu + 
0.04% Fe 1005.20 294.12 35.09 150.63 
L.S 
L.S 
•%.05b 
•D*o.oi 
70.86 
95.68 
30.60 
41.32 
11.59 
15.66 
92.83 
125.36 
aEach figure represents the mean of four animals. 
bLeast significant difference at specified proba- 
bility levels. 
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TABLE 7 
EFFECTS OF VARIOUS SUPPLEMENTS ON MINERAL DEPOSITION 
IN THE BONES OF YOUNG RATS FED HIGH LEVELS OF 
DIETARY MANGANESE (EXPERIMENT 3) 
Diet 
Bone Cons tituents3 
Ca Mg Mn P 
mg ./gm. dry weight 
Basal 214.40 1.34 0.014 65.51 
1.0% Mn 219.37 1.60 0.037 63.21 
1.0% Mn + 
dried 
10% Distiller's 
solubles 209.33 1.56 0.021 48.2 3 
1.0% Mn + 0.8% Ca + 0.8% P 224.27 1.48 0.020 31.30 
1.0% Mn + 10% Soybean meal 189.94 1.56 0.024 57.79 
1.0% Mn + 10% Extra casein 197.52 1.92 0.026 46.55 
1.0% Mn + 10% Alpha protein 146.63 1.67 0.052 80.29 
1.0% Mn + 10% Lactalbumin 160.12 1.44 0.043 47.18 
1.0% Mn + 10% Blood albumin 175.52 1.79 0.040 42.87 
1.0% 
c 
Mn + 
.04% 
0.02% Cu + 
Fe 176.45 1.72 0.036 56.19 
L.SoD. 
L„S.D. 
0.05b 
0.01 
44.77 0.45 0.010 28.51 
61.33 0.62 0.014 39.05 
aEach figure represents the mean of three animals. 
bLeast significant difference at specified proba- 
bility levels. 
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manganese on weight gain. 
The addition of 0.02% of copper + 0.04% of iron com- 
pletely alleviated the adverse effect of manganese on 
hemoglobin levels and on the deposition of iron in the 
liver.  Animals receiving the high manganese diet supple- 
mented with copper and iron had liver copper levels which 
were approximately 60 times greater than those found in the 
control animals.  The addition of the alpha protein supple- 
ment to the high manganese diet resulted in an additional 
increase in liver manganese deposition which was signifi- 
cantly higher (p^0.05) than the level of manganese 
deposited in the livers of the animals receiving only 
manganese.  The addition of either casein, alpha protein, 
blood albumin, or copper plus iron supplements to the high 
manganese diet resulted in some increase in zinc deposition 
in the liver.  These increases, however, were not signifi- 
cantly different from the liver zinc levels observed in the 
control animals.  In this experiment the presence of 1.0% 
of added manganese to the diet of young rats had no signi- 
ficant effect on the deposition of calcium, phosphorus, and 
magnesium in the bones of the animals but was associated 
with a highly significant increase (p^O.01) in manganese 
deposition in the bones. 
Analysis of the bone data gathered from this experi- 
ment also revealed that some of the supplements added to the 
high manganese diet were associated with significant changes 
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in bone mineral deposition.  The presence of alpha protein 
in the high manganese diet was associated with a level of 
bone manganese which was significantly higher than that 
found in the non-supplemented manganese-fed rats.  Manganese- 
fed animals supplemented with alpha protein or lactalbumin 
had bone calcium levels which were significantly lower 
(p ^ 0.01) than those found in the control animals.  The 
addition of a calcium plus phosphorus supplement to the high 
manganese diet resulted in a level of bone phosphorus which 
was significantly lower (p^0.05) than the bone phosphorus 
level of the control animals.  Supplements of extra casein 
and blood albumin were associated with bone magnesium levels 
which were significantly higher (p*i0.05) than those of 
the control animals. 
CHAPTER V 
GENERAL DISCUSSION 
Results of this study indicated that the overall 
effects of high levels of dietary manganese from various 
chemical sources on young rats were similar.  There were 
differences in the degree of response of the animals to 
diets containing the different manganese compounds, but the 
reasons for these differences were not apparent.  There is 
the possibility that manganese from the three compounds 
used in this study was not absorbed into the animal body to 
the same extent.  If this supposition is true, differences 
in animal responses would have been expected.  Underwood 
(23), however, states that there were no differences in 
responses among poultry maintained on diets supplemented 
with the oxide, chloride, sulfate, or carbonate forms of 
manganese. 
Although the results of this study confirm earlier 
studies that high levels of dietary manganese are associated 
with significant decreases in the growth of young rats, the 
exact nature of the interference of manganese with the 
growth mechanism(s) remains a mystery.  The addition of a 
high manganese level to the diet could render the diet so 
unpalatable that the rats refuse to eat it.  If an animal 
.Ji 
24 
did not eat, this would suggest that the depressing effect 
of manganese on growth was caused largely by reduced food 
consumption.  On the other hand, there is the possibility 
that the depressing effect on growth is the result of an 
interference with some growth mechanism(s) and that the 
depression in feed consumption is a result of this inter- 
ference.  Results of this study which show that a supple- 
ment of distiller's dried solubles will partially alleviate 
the subnormal growth associated with high levels of dietary 
manganese, however, suggest that some necessary growth 
factor(s) is involved.  These findings could be interpreted 
to mean that manganese, in some way, interferes with or 
eliminates some factor(s) necessary for growth and that the 
distiller's dried solubles furnishes this factor.  Results 
of this investigation revealed that the distiller's dried 
solubles supplement gave better protection against growth 
depression caused by a high manganese diet than did supple- 
ments of other protein sources furnishing equal or greater 
amounts of protein to the diet.  These data suggest that 
the manganese toxicity alleviating factor is not dietary 
protein per se.  The fact that increasing the level of 
casein in the diet of the manganese-fed rats from 19% to 
2 9% resulted in a further growth depression suggests that 
a high protein level may accentuate the effect of manganese 
toxicity under certain conditions. 
Results of this study confirm the findings of Gubler 
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et al. (9) and Hartman et al. (11) that high levels of 
dietary manganese intake are associated with marked 
decreases in liver iron levels.  The fact that the adverse 
effect of manganese on iron deposition in the liver was 
completely alleviated by iron supplementation indicates a 
possible iron-manganese interrelationship existing within 
the animal body.  The nature of the interference of manganese 
with iron metabolism is not apparent from the data collected 
in this study.  Hartman e_t a_l. (11) suggested that excessive 
manganese either converted iron to a form which was physio- 
logically unavailable to the animal or in some manner 
antagonizes the enzyme systems that oxidize or reduce iron 
at the site of absorption.  Results of Judd (24) indicated 
that manganese interfered with iron absorption by blocking 
the mechanism involved in the lowering of the mucosal block. 
If the main effect of manganese on iron is to convert the 
iron into a form that is unavailable to the animal, the 
iron supplement could be alleviating the effect of man- 
ganese by supplying the animal with an available form of 
iron to replace that which has been lost by the action of 
manganese. 
Hartman et al. (11) found that high levels of dietary 
manganese, in the sulfate form, resulted in marked increases 
in liver copper levels in lambs, and the results of one 
experiment of this study are in agreement with these find- 
ings.  Gubler et al. (9), however, reported that excess 
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manganese, in the chloride form, had no apparent effect on 
the deposition of copper in the livers of rats.  In this 
study, excessive manganese, in the chloride form, was found 
to have no apparent effect on liver copper deposition.  The 
overall results of this study, however, do not give a clear 
indication of the exact effect of manganese on copper 
metabolism.  The marked increase in liver copper levels in 
manganese-fed rats supplemented with copper observed in 
this study is similar to the results of Gubler et al. and 
indicates the possibility of a copper-manganese interrela- 
tionship in the animal body. 
Excess manganese in the diet resulted in marked 
decreases in hemoglobin concentrations in young rats which 
could be alleviated with a copper and iron supplement. 
Matrone et al. (12) reported that supplements of iron over- 
came the depressing effect of manganese on the hemoglobin 
formation of baby pigs.  Gubler et al. (9) found that 
supplements of copper did not completely alleviate the 
adverse effect of manganese on hemoglobin formation in 
rats.  iron supplementation probably furnished iron needed 
for hemoglobin formation to replace that lost by the adverse 
effect of manganese since the results of Hartman et al. (11) 
indicated that manganese interfered with iron absorption 
rather than with hematopoiesis. 
The adverse effect of excessive manganese on bone 
mineralization reported by Chornock et al. (13) was not 
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observed in this study.  The overall results of this investi- 
gation revealed no apparent effect on bone calcium, phos- 
phorus, and magnesium levels. 
Excessive manganese in the diets of young rats was 
associated with marked increases in the deposition of this 
mineral in the bones and the livers.  With the exception of 
calcium and phosphorus, none of the supplements tested in 
this study prevented the marked increase in tissue man- 
ganese deposition.  Excess dietary calcium and phosphorus 
have been reported to increase the dietary requirements of 
manganese (23, 25) and there is the possibility that the 
added calcium and phosphorus facilitated the removal of 
some of the excessive manganese from the animals fed this 
ration in this experiment.  If this is true, the amount of 
excessive manganese that would be available for absorption 
by the animal would be decreased, and one would expect 
some change in manganese deposition in certain body tissues 
such as the liver and bone. 
^ 
CHAPTER VI 
SUMMARY AND RECOMMENDATIONS 
Summary 
The purpose of this study was to investigate the 
nature of the interference of high levels of dietary man- 
ganese on growth, hemoglobin levels, bone mineralization, 
and metabolism of copper, iron, zinc, and manganese in young 
rats. 
Specific experiments were designed (1) to determine 
the changes which occur in young rats receiving diets 
containing high levels of manganese from various sources, 
(2) to study the effects of different levels of dietary 
manganese on the animal body, and (3) to investigate the 
possibility of alleviating the effects of manganese toxicity 
by the addition of supplements from various sources. 
The criteria used to measure the response of animals 
to individual treatments were weight gain, hemoglobin levels, 
bone levels of calcium, magnesium, manganese, and phosphorus, 
and liver content of copper, iron, manganese, and zinc. 
All data were analyzed by standard statistical procedures. 
Results from the first experiment showed that the 
addition of high levels of manganese to the diets of young 
rats produced marked decreases in weight gain, hemoglobin 
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levels, and liver iron deposition.  Manganese and zinc 
retention were increased in all cases.  In general, results 
from feeding all forms of manganese were similar. 
Data from the second experiment indicate that a 
supplement of 1.0% of manganese resulted in a significant 
loss of weight.  Hemoglobin and iron levels were decreased 
and liver manganese levels were increased with each eleva- 
tion in the level of manganese consumed.  Although copper 
retention was reduced when manganese comprised 0.5% of the 
diet, this element was increased when the other levels 
were fed.  Zinc retention was increased by feeding man- 
ganese in the first experiment; however, the opposite 
effect was produced in this experiment. 
Bone levels of calcium were decreased at the 0.2 5% 
and 0.5% levels of manganese intake and sharply elevated 
at the 1.0% level.  This level was also associated with a 
marked decrease in bone magnesium.  The concentration of 
phosphorus in the bone varied with a decrease at the 0.25% 
level, and a sharp increase at the highest level of man- 
ganese intake.  Bone deposition of manganese increased as 
intake rose, indicating that the animal body absorbs this 
mineral in proportion to intake. 
The results from the experiment using various supple- 
ments to alleviate the adverse effects of manganese toxicity 
on growth indicate that additional protein, with the excep- 
tion of distiller's dried solubles and soybean meal, produces 
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a further deleterious effect.  Although a supplement of 
copper + iron maintained hemoglobin levels and liver iron 
deposition, this supplement was associated with a marked 
decrease in growth.  This supplement was also responsible 
for a high increase in liver copper deposition.  Addition 
of calcium + phosphorus was responsible for preventing 
the large increases of manganese evident in all other 
supplemented diets.  Extra casein, alpha protein, blood 
albumin, and copper + iron supplements were associated with 
a marked increase in liver zinc deposition.  With the 
exception of manganese, bone mineralization was not signi- 
ficantly affected by the supplemented diets. 
Recommendations for Additional Investigations 
The functions ascribed to manganese are increasing 
in number with the widespread accumulation of information 
and experience concerning this mineral.  Evidence that 
excesses of manganese produce adverse effects on other 
dietary components has stimulated research to determine 
the exact nature of these interrelationships. 
Results from this study have not indicated any clear 
cut effect of high levels of manganese on the utilization of 
calcium and phosphorus by the rat.  The data, however, show 
that the calcium plus phosphorus supplement seems to effect 
a decrease in manganese retention.  This finding suggests 
that an interrelationship may exist among these minerals. 
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Metabolic studies could be made to further investigate this 
possibility. 
Although a high level of dietary manganese seems to 
have no effect on liver deposition of copper, liver iron 
deposition and hemoglobin levels are sharply reduced.  Data 
from this study show that these levels are returned to those 
of the control animals when a copper plus iron supplement 
is fed.  The interference appears to exist between the high 
level of manganese in the diet and the utilization of iron. 
Results from this study suggest the possibility that high 
levels of manganese may also interfere with enzymes such as 
cytochrome oxidase, catalase, and succinic dehydrogenase 
which require iron as a cofactor.  If manganese toxicity 
results in an iron deficiency, then it is possible that 
iron-containing enzymes would be adversely affected by high 
levels of dietary manganese.  It would be of interest to 
conduct enzymatic studies to obtain further information. 
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TABLE   1 
EFFECTS   OF   TREATMENTS   TESTED   IN   EXPERIMENT   1 
ON   GROWTH   OF   RATS 
Repli- 
cations Basal 
Treatments 
1.0% Mn        1.0% Mn      1.0% Mn 
(MnS04-H_0)    (MnCl2-4H20)    (MnC03) 
4 weeks weight gain (gm.) 
1 189 85 
2 213 101 
3 185 84 
4 107 83 
5 175 102 
6 202 77 
7 146 83 
8 193 98 
Total 1410 713 
Mean 176 89 
189 30 
73 50 
76 2 
85 5 
81 4 
94 40 
76 59 
79 33 
753 223 
94 28 
TABLE 2 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 1 
ON HEMOGLOBIN LEVELS 
Repli- 
cations Basal 
Treatments 
1.0% Mn        1.0% Mn 
(MnS04-H20)    (MnCl2-4H20) 
1.0% Mn 
(MnC03) 
gm. /100 ml. blood 
1 11.5 7.3 7.9 7.8 
2 12.2 8.7 6.1 6.0 
3 12.5 7.3 7.3 7.2 
4 12.1 7.5 6.1 6 7 
5 12.2 7.5 6.5 5.7 
6 12.9 11.8 6.7 6.1 
7 12.4 8.0 5.1 4.7 
8 11.8 6.3 5.9 8.5 
Total 97.5 64.5 51.5 52.7 
Mean 12.1 8.1 6.4 6.6 
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TABLE 3 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 1 
ON LIVER COPPER LEVELS 
Trea tments 
Repli- 
cations Basal 
1.0% Mn 
(MnS04-H20) 
1.0% Mn 
(MnCl2-4H2 0) 
1.0% Mn 
(MnC03) 
meg. /gm. dry weight 
1 22.2 41.4 22.4 24.5 
2 24.6 16.4 14.8 38.9 
3 15.3 16.5 15.0 31.1 
4 25.2 51.9 19.8 31.5 
Total 87.2 126.2 72.0 125.9 
Mean 21.8 31.6 18.0 31.5 
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TABLE 4 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 1 
ON LIVER IRON LEVELS 
Treatments 
Repli- 
cations Basal 
1.0% Mn 
(MnS04-H20) 
1.0% Mn 
(MnCl2-4H2 0) 
1.0% Mn 
(MnC03) 
meg. /gm. dry weight 
1 341.9 275.9 122.9 151.7 
2 420.2 126.9 114.0 106.9 
3 326.0 144.3 111.2 124.9 
4 341.0 183.4 125.9 96.3 
Total 1429.1 730.5 474.1 479.9 
Mean 357.3 182.6 118.5 120.0 
I 
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TABLE 5 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 1 
ON LIVER MANGANESE LEVELS 
Treatments 
Repli- 
cations Basal 
1.0% Mn 
(MnS04-H20) 
1.0% Mn 
(MnCl2.4H2 0) 
1.0% Mn 
(MnC03) 
meg. /gm. dry  weight 
1 4.7 71.1 20.9 28.4 
2 6.2 49.6 36.3 24.3 
3 6.4 57.8 31.1 29.4 
4 7.4 117.4 63.8 35.0 
Total 24.7 295.8 152.1 117.2 
Mean 6.2 74.0 38.0 29.3 
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TABLE 6 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 1 
ON LIVER ZINC LEVELS 
Treatments 
Repli- 
cations Basal 
1.0% Mn 
(MnS04-H20) 
1.0% Mn 
(MnCl2-4H2 0) 
1.0% Mn 
(MnC03) 
meg. /gm. dry weight 
1 50.6 142.0 61.9 29.4 
2 49.6 51.0 52.8 62.5 
3 29.3 46.8 73.3 75.5 
4 52.5 89.3 35.6 64.4 
Total 182.1 329.0 223.5 231.7 
Mean 45.5 82.3 55.9 57.9 
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TABLE 7 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 2 
ON THE GROWTH OF RATS 
Repli- 
cations Basal 
Tre 
0.25% Mn 
atments 
0.5% Mn 1.0% Mn 
4 weeks weight gain (gm.) 
1 203 195 186 88 
2 216 188 192 86 
3 187 200 182 79 
4 209 202 203 120 
5 200 207 195 84 
6 213 178 157 104 
7 198 183 203 117 
8 203 168 208 82 
Total 1629 1521 1526 760 
Mean 204 190 191 95 
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TABLE 8 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 2 
ON HEMOGLOBIN LEVELS 
Repli- 
cations Basal 
Trea 
0.25% Mn 
tments 
0.5% Mn 1.0% Mn 
gm./lOO ml. blood 
1 13.5 12.5 8.7 8.0 
2 12.8 11.5 9.2 7.6 
3 12.4 11.8 10.5 6.6 
4 13.2 11.9 10.4 7.5 
5 12.8 11.8 10.1 7.5 
6 13.1 12.4 10.5 8.2 
7 12.9 11.8 9.8 8.4 
8 13.1 11.8 11.4 7.1 
Total 103.8 95.5 80.5 60.8 
Mean 13.0 11.9 10.1 7.6 
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TABLE 9 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 2 
ON LIVER COPPER LEVELS 
Repli- 
cations Basal 
Treatments 
0.2 5% Mn      0.5% Mn 1.0% Mn 
meg./gm. dry weight 
1 8.6 9.5 4.2 6.9 
2 8.4 7.9 7.6 7.9 
3 7.0 10.0 7.0 8.6 
4 9.5 7.7 8.4 11.0 
5 10.6 8.9 10.0 8.0 
6 13.0 8.4 8.2 10.3 
7 8.4 8.0 7.2 13.5 
8 10.5 13.5 9.3 8.0 
Total 76.0 73.9 61.9 74.2 
Mean 9.5 9.2 7.7 9.3 
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TABLE   10 
EFFECTS   OF   TREATMENTS   TESTED   IN   EXPERIMENT   2 
ON   LIVER   IRON  LEVELS 
Repli- 
cations Basal 
Trea 
0.25% Mn 
tments 
0.5% Mn 1.0% Mn 
meg./gm. dry weight 
1 246.2 129.9 136.3 54.4 
2 213.9 128.4 55.6 43.8 
3 156.1 121.2 44.9 62.4 
4 263.4 126.3 86.3 75.8 
5 181.3 137.7 136.9 54.1 
6 309.7 136.9 70.5 64.3 
7 221.7 133.8 91.6 68.4 
8 189.9 123.8 82.9 38.0 
Total 1782.2 1038.0 705.0 461.2 
Mean 222.8 129.8 88.1 57.7 
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TABLE 11 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 2 
ON LIVER MANGANESE LEVELS 
Repli- 
cations Basal 
Treatments 
0.25% Mn     0.5% Mn 1.0% Mn 
meg./gm. dry weight 
1 2.7 5.5 12.2 8.4 
2 3.9 5.8 9.3 8.4 
3 4.4 6.6 11.7 27.8 
4 3.5 8.6 8.3 24.3 
5 3.6 9.4 10.8 18.0 
6 4.2 6.6 14.8 16.3 
7 4.5 8.2 10.7 55.2 
8 3.8 10.7 14.0 16.5 
Total 30.6 61.4 91.7 174.7 
Mean 3.8 7.7 11.5 21.8 
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TABLE 12 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 2 
ON LIVER ZINC LEVELS 
Repli- 
cations Basal 
Tre. 
0.25% Mn 
atments 
0.5% Mn 1.0% Mn 
meg./gm .   dry weight 
1 57.5 60.8 56.5 48.0 
2 50.5 58.5 53.3 38.4 
3 61.5 64.7 62.1 48.4 
4 71.9 59.0 51.3 54.8 
5 55.4 72.2 53.3 54.0 
6 59.3 66.5 55.5 48.4 
7 127.1 61.0 58.0 44.9 
8 53.4 64.2 58.6 47.0 
Total 536.6 507.0 448.4 383.7 
Mean 67.1 63.4 56.1 48.0 
1 
49 
TABLE 13 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 2 
ON BONE CALCIUM LEVELS 
Repli- 
cations Basal 
Tre 
0.25% Mn 
atments 
0.5% Mn 1.0% Mn 
mg./gm. dry weight 
1 1321.6 399.9 2442.9 4562.8 
2 580.4 1423.0 789.9 2623.4 
3 524.9 742.9 557.8 2469.5 
4 501.7 541.6 924.7 815.8 
5 414.6 439.1 488.6 2450.9 
6 469.1 571.4 1302.2 2238.3 
7 1991.4 1039.5 649.2 4328.1 
8 2571.0 667.0 472.9 852.7 
Total 8374.6 5824.4 7628.3 20341.6 
Mean 1046.8 728.0 953.5 2542.7 
"1 
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TABLE   14 
EFFECTS   OF   TREATMENTS   TESTED   IN  EXPERIMENT   2 
ON  BONE  MAGNESIUM LEVELS 
Treatments 
Repli- 
cations Basal 0.25% Mn 0.5% Mn 1.0% Mn 
mg./gm. dry weight 
1 5.1 3.7 3.5 2.1 
2 4.2 4.4 3.9 1.9 
3 4.6 4.0 3.5 1.8 
4 3.5 4.2 3.6 1.8 
5 2.2 2.2 3.0 2.3 
6 3.5 2.7 2.2 2.2 
7 2.6 3.0 3.5 1.8 
8 2.4 2.4 2.5 1.5 
Total 28.1 26.5 25.6 15.3 
Mean 3.5 3.3 3.2 1.9 
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TABLE   15 
EFFECTS   OF  TREATMENTS   TESTED   IN  EXPERIMENT  2 
ON   BONE   MANGANESE   LEVELS 
Repli- 
cations Basal 
Treatments 
0.25% Mn               0.5% Mn 1.0% Mn 
racg./gm. dry weight 
1 15.8 15.7 15.3 31.6 
2 10.0 12.5 16.7 28.1 
3 12.3 13.5 12.3 27.6 
4 12.0 13.1 12.9 27.0 
5 11.5 13.0 13.4 28.1 
6 15.3 13.8 18.1 27.3 
7 11.5 13.3 13.7 25.0 
8 12.1 11.8 14.0 26.7 
Total 100.3 106.7 116.4 221.4 
Mean 12.5 13.3 14.6 27.7 
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TABLE 16 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 2 
ON BONE PHOSPHORUS LEVELS 
Repli- 
cations Basal 
Treatments 
0.25% Mn      0.5% Mn 1.0% Mn 
rag./gm. dry weight 
1 139.8 91.7 121.1 165.9 
2 79.9 94.1 92.1 106.7 
3 63.9 52.2 81.8 195.9 
4 67.2 43.2 87.0 88.4 
5 73.3 55.7 86.5 134.8 
6 57.0 75.2 106.1 191.0 
7 114.4 116.6 61.2 203.7 
8 110.6 54.9 94.3 157.2 
Total 706.2 583.6 730.2 1243.6 
Mean 88.3 72.9 91.3 155.5 
TABLE 17 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON GROWTH OF RATS 
Tre atments 
1    Ra«al 6. 1 0% Mn + 10% Extra casein 
2. 1. 
3. 1. 
4. 1 
5. 1 
0% 
0% 
0% 
0% 
Manganese 
Mn + 10% 
Mn + 0.8% 
Mn + 10% 
Distille 
Ca + 0. 
Soybean 
r's di 
8% P 
meal 
ied solubles 
7. 
8. 
9. 
10. 
1 
1 
1 
1 
0% Mn 
.0% Mn 
.0% Mn 
.0% Mn 
+ 
+ 
+ 
+ 
10% Alpha protein 
10% Lactalbumin 
10% Blood albumin 
0.02% Cu + 0.04% Fe 
Treatments 
Reps 1 2 3 4 5 6 7 8 
9 10 
4 weeks we ight gain (gm.) 
1 163 112 158 66 112 106 43 
32 96 7 
2 193 145 147 154 140 36 62 
90 63 96 
3 197 129 155 100 146 57 
42 42 103 34 
4 137 138 147 141 144 107 
(42)a 11 76 35 
5 199 130 156 157 143 131 
80 75 72 1 
6 195 112 157 41 133 117 
13 117 93 59 
Total 1084 766 920 659 818 
554 282 367 503 232 
Mean 181 128 153 110 136 92 
47 61 84 39  w 
LO 
a( ) indicates calculated missing plot value. 
TABLE 18 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON HEMOGLOBIN LEVELS 
Treatments 
1. Basal 
2. 1.0% Manganese 
3. 1.0% Mn + 10% Disti 
4. 1.0% Mn + 0.8% Ca + 
5. 1.0% Mn + 10% Soybe 
ller's dried solubles 
0.8% P 
an meal 
6. 
7. 
8. 
9. 
10. 
1 
1 
1 
1 
1 
.0% Mn 
.0% Mn 
.0% Mn 
.0% Mn 
.0% Mn 
+ 
+ 
+ 
+ 
+ 
10% Extra casein 
10% Alpha protein 
10% Lactalbumin 
10% Blood albumin 
0.02% Cu + 0.04% Fe 
Treatments 
Reps 1 2 3 4 5 6 7 8 9 10 
gm./lOO ml. blood 
1 12.7 8.7 8.1 9.1 7.5 8.3 7.8 9.2 8.7 15.5 
2 13.0 8.7 8.4 8.1 8.2 7.8 7.8 7.9 8.7 12.8 
3 12.8 8.2 8.8 8.5 7.8 8.3 7.7 7.8 9.5 13.8 
4 11.5 11.1 8.3 8.3 8.9 8.3 13.4 9.6 7.9 11.5 
5 12.3 7.6 9.7 8.7 6.5 7.9 7.5 7.9 7.7 12.4 
6 12.8 8.2 8.5 9.8 7.5 8.1 9.1 8.1 10.1 11.2 
Total 75.0 52.5 52.0 52.4 46.5 48.8 53.3 50.6 52.6 77.1 
Mean 12.5 8.8 8.7 8.7 7.7 8.1 8.9 8.4 8.8 12.9 
TABLE 19 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON LIVER COPPER LEVELS 
Treatments 
1. Basal 
2. 1.0% Manganese 
3. 1.0% Mn + 10% Distiller's dried solubles 
4. 1.0% Mn + 0.8% Ca + 0.8% P 
5. 1.0% Mn + 10% Soybean meal 
6. 1.0% Mn + 10% Extra casein 
7. 1.0% Mn + 10% Alpha protein 
8. 1.0% Mn + 10% Lactalbumin 
9. 1.0% Mn + 10% Blood albumin 
10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Reps 
Treatments 
4      5 10 
meg./gm. dry weight 
1 20.6 15.1 25.3 20.1 13.3 25.2 56.9 17.0 19.5 1048.5 
2 15.8 13.1 12.5 14.7 9.7 17.4 30.3 12.3 18.7 946.7 
3 19.7 29.6 22.1 21.2 15.4 19.7 33.9 18.0 19.5 832.1 
4 13.9 19.9 23.1 11.2 15.5 19.9 40.4 63.8 15.8 1193.5 
Total 70.0 77.7 82.9 67.2 53.9 82.2 151.5 111.1 73.5 4020.8 
Mean 17.5 19.4 20.7 16.8 13.5 20.6 37.9 27.8 18.4 1005.2 
Ul 
Ul 
TABLE 20 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON LIVER IRON LEVELS 
Treatments 
1. Basal 
2. 1.0% Manganese 
3. 1.0% Mn + 10% Distiller's dried solubles 
4. 1.0% Mn + 0.8% Ca + 0.8% P 
5. 1.0% Mn + 10% Soybean meal 
6. 1.0% Mn + 10% Extra casein 
7. 1.0% Mn + 10% Alpha protein 
8. 1.0% Mn + 10% Lactalbumin 
9. 1.0% Mn + 10% Blood albumin 
10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Reps 1 
Treatments 
4       5 
mcg./gm. dry weight 
1 337.2     85.4    82.0    92.9    84.3    87.2 98.9 103.1 
2 242.0           108.2           87.2           72.9           90.7           93.2 104.8 91.4 
3 334.2              95.4           85.2           92.3           80.9           93.5 85.9 105.0 
4 291.4            98.2          83.8          93.0          87.8          94.9 109.9 135.1 
107.6 
100.5 
92.4 
85.8 
10 
320.5 
339.6 
274.4 
242.0 
Total  1204.8    387.2 
Mean    301.2     96.8 
338.1      351.1 343.7 368.8 
84.5 87.8 85.9 92.2 
399.5        434.7 386.3 1176.5 
99.9        108.7 96.6 294.1 
TABLE 21 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON LIVER MANGANESE LEVELS 
Treatments 
1. Basal 6. 1.0% Mn + 10% Extra casein 
2. 1.0% Manganese 7. 1.0% Mn + 10% Alpha protein 
3. 1.0% Mn + 10% Distiller's dried solubles 8. 1.0% Mn + 10% Lactalbumin 
4. 1.0% Mn + 0.8% Ca + 0.8% P 9. 1.0% Mn + 10% Blood albumin 
5. 1.0% Mn + 10% Soybean meal 10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Treatments 
Reps 1 2 3 4 5 6 7 8 9 10 
meg./gm. dry weight 
1 4.7 31.7 14.8 10.5 24.8 24.2 57.0 18.1 39.0 49.6 
2 4.6 41.2 20.0 9.7 19.4 27.0 41.0 24.3 32.3 19.8 
3 5.2 22.2 21.6 9.1 20.9 9.7 35.9 39.3 41.6 40.8 
4 4.3 23.9 16.7 9.4 21.2 16.4 31.8 43.5 31.1 30.2 
Total 18.7 119.0 73.2 38.7 86.3 77.3 165.7 125.1 143.9 140.4 
Mean 4.7 29.7 18.3 9.7 21.6 19.3 41.4 31.3 36.0 35.1 
TABLE 22 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON LIVER ZINC LEVELS 
Treatments 
1. Basal 6. 1.0% Mn + 10% Extra casein 
2. 1.0% Manganese 7. 1.0% Mn + 10% Alpha protein 
3. 1.0% Mn + 10% Distiller's dried solubles 8. 1.0% Mn + 10% Lactalbumin 
4. 1.0% Mn + 0.8% Ca + 0.8% P 9. 1.0% Mn + 10% Blood albumin 
5. 1.0% Mn + 10% Soybean meal 10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Treatments 
Reps 1 23456789 10 
mcg./gm. dry weight 
1 89.3     87.9    83.6    86.6    93.1    78.2 
2 70.6     72.9    75.8    66.8    80.9    93.2 
3 61.4     75.7    68.8    82.9    71.0    77.3 
4 72.7     91.0    58.1    94.0    73.5   164.0 
Total   294.0    327.5   286.2   330.3   318.4   412.8   594.4   354.7   540.3   602.5 
Mean     73.5     81.9    71.6    82.6    79.6   103.2   148.6    88.7   135.1   150.6 
100.6 103.2 77.3 343.6 
81.8 87.3 69.4 79.9 
94.0 75.1 83.0 76.3 
318.0 89.1 310.7 102.7 
CO 
TABLE 23 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON BONE CALCIUM LEVELS 
Treatments 
1. Basal 6. 1.0% Mn + 10% Extra casein 
2. 1.0% Manganese 7. 1.0% Mn + 10% Alpha protein 
3. 1.0% Mn + 10% Distiller's dried solubles 8. 1.0% Mn + 10% Lactalbumin 
4. 1.0% Mn + 0.8% Ca + 0.8% P 9. 1.0% Mn + 10% Blood albumin 
5. 1.0% Mn + 10% Soybean meal 10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Treatments 
Reps 123456789 10 
mg./gm. dry weight 
1 195.7          204.6       202.7        218.6 176.3        176.6 83.9 90.4 143.2 160.4 
2 229.6           235.6        195.8        247.5 186.3         216.2 222.2 186.0 196.8 193.3 
3 217.9           217.9        229.5         206.7 207.3         199.8 132.9 203.9 186.6 175.7 
Total        643.2           658.1        628.0        672.8 569.9        592.6 439.0 480.3 526.6 529.4 
Mean          214.4          219.4       209.3        224.3 189.9       197.5 146.3 160.1 175.5 176.4 
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TABLE 24 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON BONE MAGNESIUM LEVELS 
Treatments 
1. Basal 
2. 1.0% Manganese 
3. 1.0% Mn + 10% Distiller's dried solubles 
4. 1.0% Mn + 0.8% Ca + 0.8% P 
5. 1.0% Mn + 10% Soybean meal 
6. 1.0% Mn + 10% Extra casein 
7. 1.0% Mn + 10% Alpha protein 
8. 1.0% Mn + 10% Lactalbumin 
9. 1.0% Mn + 10% Blood albumin 
10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Reps 
Treatments 
4      5 8 10 
mg./gm. dry weight 
1 1315.0    1674.5  1881.0  1463.0  1343.8  2233.9 1241.6 1146.7 1374.4 1526.0 
2 1318.1    1574.3  1296.0  1469.4  1403.9  1705.4 1966.8 1403.3 2062.1 1597.9 
3 1401.7    1550.9  1499.1  1511.6  1932.5  1813.2 1801.0 1785.0 1943.5 2042.5 
Total 4034.8 
Mean  1344.9 
4799.6  4676.0  4444.1  4680.2  5752.5  5009.5  4335.0  5380.0  5166.4 
1599.9  1558.7  1481.4  1560.1  1917.5  1669.8  1445.0  1793.3  1722.1 
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TABLE 25 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON BONE MANGANESE LEVELS 
Treatments 
1. Basal 
2. 1.0% Manganese 
3. 1.0% Mn + 10% Distiller's dried solubles 
4. 1.0% Mn + 0.8% Ca + 0.8% P 
5. 1.0% Mn + 10% Soybean meal 
6. 1.0% Mn + 10% Extra casein 
7. 1.0% Mn + 10% Alpha protein 
8. 1.0% Mn + 10% Lactalbumin 
9. 1.0% Mn + 10% Blood albumin 
10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Reps 
Treatments 
4      5 
1 14.9 19.1 20.6 15.1 23.1 
2 12.1 42.5 21.4 21.4 27.1 
3 13.5 50.7 20.3 23.8 22.8 
Total 40.5 112.3 62.3 60.4 73.0 
Mean 13.5 37.4 20.8 20.1 24.4 
mcg./gm. dry weight 
25.7 50.6 
23.6 56.7 
28.6 49.8 
10 
45.4    40.8    38.2 
40.9    44.1   (37.6)a 
41.4    36.5    33.0 
77.9   157.1   127.8   121.4   108.8 
26.0    52.4    42.6    40.5    36.3 
( ) indicates calculated missing plot value. 
(^ 
TABLE 26 
EFFECTS OF TREATMENTS TESTED IN EXPERIMENT 3 
ON BONE PHOSPHORUS LEVELS 
Treatments 
1. Basal 
2. 1.0% Manganese 
3. 1.0% Mn + 10% Distiller's dried solubles 
4. 1.0% Mn + 0.8% Ca + 0.8% P 
5. 1.0% Mn + 10% Soybean meal 
6. 1.0% Mn + 10% Extra casein 
7. 1.0% Mn + 10% Alpha protein 
8. 1.0% Mn + 10% Lactalbumin 
9. 1.0% Mn + 10% Blood albumin 
10. 1.0% Mn + 0.02% Cu + 0.04% Fe 
Reps 
Treatments 
4      5 8 
1 100.5 87.0 69.0 31.9 
2 26.9 47.5 44.3 32.1 
3 69.1 55.2 31.4 30.0 
Total 196.6 189.7 144.7 94.0 
Mean 65.5 63.2 48.2 31.3 
mg./gm. dry weight 
82.2 72.2 149o3 
51.3 31.3 26.1 
39.9    36.1 65.5 
10 
23.7 21.6    54.8 
61.8 59.6    24.4 
56.1    47.5    89.3 
173.4       139.6       240.9        141.6        128.7        168.5 
57.8 46.5 80.3 47.2 42.9 56.2 
to 
APPENDIX B 
ANALYSIS OF VARIANCE DATA 
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TABLE 1 
ANALYSES OF VARIANCE OF DATA COLLECTED IN EXPERIMENT 1 
Source of 
Variation 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Total 
Replications 
Treatments 
Error 
Weight 
31 
7 
3 
21 
Gain 
111,996 
7,218 
89,032 
15,747 
29,677** 
750 
Total 
Replications 
Treatments 
Error 
Hemoglobin 
31 
7 
3 
21 
Level 
209.35 
8.34 
171.58 
29.43 
57.19** 
1.40 
Total 
Replications 
Treatments 
Error 
Liver Copper 
15           2,248.65 
3             329.09 
3            1,077.41 
9              842.15 
359.14 
93.57 
65 
TABLE 1—Continued 
Source of 
Variation 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Total 
Replications 
Treatments 
Error 
15 
3 
3 
9 
Liver Iron 
172,478.19 
4,825.83 
151,846.95 
15,805.41 
50 
1 
,615.65** 
,756.16 
Total 
Replications 
Treatments 
Error 
Li 
15 
3 
3 
9 
ver Manganese 
13,321.77 
1,947.29 
9,507.67 
1,866.81 
3 ,169.22** 
207.42 
Total 
Replications 
Treatments 
Error 
15 
3 
3 
9 
Liver Zinc 
11,146.09 
713.39 
2,904.51 
7,528.19 
968.17* 
836.47 
*Significant (p^0.05). 
**Highly significant (p ^ 0.01). 
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TABLE 2 
ANALYSES OF VARIANCE OF DATA COLLECTED IN EXPERIMENT 2 
Source of Degrees of Sum of Mean 
Variance Freedom Squares Square 
Weight Gain 
Total 31 66,282 
Replications 7 1,407 
Treatments 3 60,729 20,243** 
Error 21 4,145 197 
Hemoglobin Level 
Total 31 142.56 
Replications 7 1.92 
Treatments 3 133.73 44.58** 
Error 21 6.91 .33 
Liver Copper 
Total 31 119.64 
Replications 7 30.52 
Treatments 3 15.68 5.22 
Error 21 73.44 3.49 
TABLE 2—Continued 
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Source of 
Variance 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Total 
Replications 
Treatments 
Error 
31 
7 
3 
21 
Liver Iron 
150,247.5 
8,770.4 
123,820.6 
17,656.5 
41,273.53** 
840.78 
Total 
Replications 
Treatments 
Error 
31 
7 
3 
21 
Liver Manganese 
3,093.95 
436.85 
1,441.06 
1,216.04 
480.35* 
57.91 
Total 
Replications 
Treatments 
Error 
31 
7 
3 
21 
Liver Zinc 
6,539.96 
1,156.00 
1,713.36 
3,670.60 
571.12 
174.79 
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TABLE   2—Continued 
Source  of 
Variance 
Degrees  of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Total 
Replications 
Treatments 
Error 
31 
7 
3 
21 
Bone Calcium 
39,907,971.61 
7,423,421.41 
16,400,248.85 
14,084,301.35 
5,466 
670 
749.61** 
681.01 
Total 
Replications 
Treatments 
Error 
31 
7 
3 
21 
Bone Phosphorus 
57,617.28 
10,038.43 
32,409.29 
15,169.56 
10 803.09* 
722.36 
Total 
Replications 
Treatments 
Error 
31 
7 
3 
21 
Bone Magnesium 
28.11 
8.53 
12.60 
6.98 
4.20** 
.33 
Total 
Replications 
Treatments 
Error 
31 
7 
3 
21 
Bone Manganese 
1,315.60 
50.59 
1,226.40 
38.61 
408.80** 
1.84 
*Significant   (p si 0.05). 
**Highly  significant   (p SSs 0.01) . 
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TABLE 3 
ANALYSES OF VARIANCE OF DATA COLLECTED IN EXPERIMENT 3 
Source of 
Variation 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Weight Gain 
Total 
Replications 
Treatments 
Error 
58 
5 
9 
45 
160,683 
4,381 
119,026 
37,275 
13 ,225** 
828 
Hemoglobin Level 
Total 
Replications 
Treatments 
Error 
59 
5 
9 
45 
235.55 
6.68 
173.18 
55.69 
19.24** 
1.24 
Liver Copper 
Total 
Replications 
Treatments 
Error 
39 
3 
9 
27 
3,557,253.30 
9,120.70 
3,483,736.79 
64,395.81 
387 
2 
081.87** 
385.03 
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TABLE  3—Continued 
Source of 
Variation 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Total 
Replications 
Treatments 
Error 
39 
3 
9 
27 
Liver Iron 
254,256.71 
2,140.59 
240,106.09 
12,010.03 
26,678.45** 
444.82 
Total 
Replications 
Treatments 
Error 
L 
39 
3 
9 
27 
iver Mang anese 
6,997.79 
114.40 
5,157.90 
1,725.49 
1,684.21** 
63.91 
Total 
Replications 
Treatments 
Error 
39 
3 
9 
27 
Liver Zinc 
172,187.21 
26,338.46 
35,321.88 
110,526.87 
3,924.65 
4,093.59 
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TABLE 3—Continued 
Source of 
Variation 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Square 
Bone Calcium 
Total 29 
Replications 2 
Treatments 9 
Error 18 
42,041.34 
11,069.69 
18,713.74 
12,257.91 
*Significant   (p^-0.05). 
**Highly   significant   (p^O.01). 
2,079.30** 
680.99 
Bone Phosphorus 
Total 29 23,010.89 
Replications 2 2,936.23 
Treatments 9 15,103.33 1,678.15 
Error 18 4,971.66 276.20 
Bone Magnesium 
Total 29 2,269,909.94 
Replications 2 229,704.20 
Treatments 9 790,726.65 87,858.52 
Error 18 1,249,489.09 69,416.06 
Bone Manganese 
Total 28 4,730.24 
Replications 2 64.13 
Treatments 9 4,037.79 448.64** 
Error 17 628.32 36.96 
